Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Angelo

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|May 21, 2021
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung CancerGiuseppe Bronte, Maurizio Puccetti, Elisabetta Petracci, et al.
Lung Cancer (Amsterdam, Netherlands)|September 24, 2015
Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysisRita Chiari, Giulio Metro, Daniela Iacono, et al.
Cancers|February 10, 2024
Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer PatientsNicola Gentili, William Balzi, Flavia Foca, et al.
Frontiers in Immunology|December 3, 2021
Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte RatioAlberto Bongiovanni, Flavia Foca, Jessica Menis, et al.
Clinical Lung Cancer|May 19, 2015
Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective AnalysisGiovenzio Genestreti, Marcello Tiseo, Hirotsugu Kenmotsu, et al.
International Journal of Molecular Sciences|January 7, 2015
Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?Paola Ulivi, Angelo Delmonte, Elisa Chiadini, et al.
Journal of Clinical Medicine|April 11, 2020
Concomitant <i>TP53</i> Mutation Confers Worse Prognosis in <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIsMatteo Canale, Elisabetta Petracci, Angelo Delmonte, et al.
Annals of Surgical Oncology|May 28, 2013
Multicenter institutional experience of surgically resected thymic epithelial tumors (TETs): an observational report on behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone)Giovenzio Genestreti, Luca Ampollini, Marco Angelo Burgio, et al.
The Journal of Craniofacial Surgery|May 18, 2018
Growth Factors Release From Concentrated Growth Factors: Effect of β-Tricalcium Phosphate AdditionVeronica Bonazza, Christopher Hajistilly, Dinker Patel, et al.
Neuroradiology|June 30, 2022
Silk Vista Baby flow diverter stent for ruptured intracranial aneurysms: a retrospective observational studyRiccardo Russo, Andrea Boghi, Andrea Giorgianni, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|May 21, 2021
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung CancerGiuseppe Bronte, Maurizio Puccetti, Elisabetta Petracci, et al.
Lung Cancer (Amsterdam, Netherlands)|September 24, 2015
Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysisRita Chiari, Giulio Metro, Daniela Iacono, et al.
Cancers|February 10, 2024
Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer PatientsNicola Gentili, William Balzi, Flavia Foca, et al.
Frontiers in Immunology|December 3, 2021
Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte RatioAlberto Bongiovanni, Flavia Foca, Jessica Menis, et al.
Clinical Lung Cancer|May 19, 2015
Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective AnalysisGiovenzio Genestreti, Marcello Tiseo, Hirotsugu Kenmotsu, et al.
International Journal of Molecular Sciences|January 7, 2015
Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?Paola Ulivi, Angelo Delmonte, Elisa Chiadini, et al.
Journal of Clinical Medicine|April 11, 2020
Concomitant <i>TP53</i> Mutation Confers Worse Prognosis in <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIsMatteo Canale, Elisabetta Petracci, Angelo Delmonte, et al.
Annals of Surgical Oncology|May 28, 2013
Multicenter institutional experience of surgically resected thymic epithelial tumors (TETs): an observational report on behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone)Giovenzio Genestreti, Luca Ampollini, Marco Angelo Burgio, et al.
The Journal of Craniofacial Surgery|May 18, 2018
Growth Factors Release From Concentrated Growth Factors: Effect of β-Tricalcium Phosphate AdditionVeronica Bonazza, Christopher Hajistilly, Dinker Patel, et al.
Neuroradiology|June 30, 2022
Silk Vista Baby flow diverter stent for ruptured intracranial aneurysms: a retrospective observational studyRiccardo Russo, Andrea Boghi, Andrea Giorgianni, et al.
Pageof 7